Drew Boxler

Blockchain technology will track intra- and inter- health care system medicine transfers.

Self-guided, online program offers 36 hours of CE credits.

Indicated for adults with moderate to severe plaque psoriasis.

The chain will now require customers to be 21 years of age to purcahse tobacco products. 

Esketamine comes with close supervision requirements. 800 clinics have already been approved and dispensed initial applications. 

FDA granted final approval to drug originally tentatively approved in 2018.

The FDA has recently approved new dosage form and two new indications for the drug. 

Courses can be implemented alongside existing educational programs.

Reimbursement reform tops list of priorities, from DIR fees to rebates.

Women no longer require nine months of contraception post cessation of the drug.

First-ever dual-drug, single tablet for HIV offers lighter treatment regimen. 

Advocates are calling for government regulations on PBMs and pharmacy.  

New report highlights the dangers of prescription medications beyond opioids. 

"Test and treat" scheme reducing stress on general practitioners. 

The program increased hypertension management rates to 77% in 2017. 

Tom Kraus to bring expeirence in government and industry.

Solriamfetol is approved for adult patients suffering from the effects of narcolepsy and OSA. 

New guide details actions for pharmacists and payers.

The next-generation oral drug is the first to be approved specifically for secondary progressive multiple sclerosis in more than 15 years.

 More than 25,000 lawsuits cite uncontrollable and irreversible bleeding and death. 

The groups say the state has intentionally suppressed dispensing fees to reimburse pharmacies that service Medicaid patients.

First drug approved for PPD use to remain under REMS program.

CHPA says over $146 billion and countless productivity hours are saved by the availability and accessibility of OTC medications and products. 

The free course will cover a myraid of drug policy issues. 

Aggregated data highlights manufacturers responsible for price increases. 

Beginning January 2020, all new employer clients must incorporate Point-of-Sale discounts.

Ongoing valsartan shortages due to recalls prompt FDA prioritization.

Indicated for breast cancer, and gastric or gastroesophageal junction adenocarcinoma.